MFS
ONCT

Mirabella Financial Services’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Mirabella Financial Services’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,355
Closed -$38K – 766
2022
Q1 		$38K Buy
+1,355
New +$49.3K ﹤0.01% 499
2021
Q1 		– Sell
-936
Closed -$92K – 456
2020
Q4 		$92K Buy
+936
New +$59.2K 0.01% 288

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

Mirabella Financial Services's ONCT Position: Q2 2022 in Review

Mirabella Financial Services sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2022, closing a stake of 1,355 shares — an estimated $38K sold.

Mirabella Financial Services first reported a position in ONCT in Q4 2020 and held it in 2 quarters. The position peaked at $92K in Q4 2020. 75 funds tracked by Wall St. Rank hold ONCT as of Q2 2022.

  • Mirabella Financial Services reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Mirabella Financial Services sold 1,355 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $38K.
  • Mirabella Financial Services first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Mirabella Financial Services's Oncternal Therapeutics, Inc. Common Stock position peaked at $92K in Q4 2020.
  • 75 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Mirabella Financial Services's 13F filing for Q2 2022, filed 12 Aug 2022.